Amedisys Stock Today

AMED Stock  USD 93.61  0.08  0.09%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 8

 
100  
 
Zero
Low
Amedisys is trading at 93.61 as of the 22nd of February 2024, a -0.09 percent decrease since the beginning of the trading day. The stock's lowest day price was 93.25. Amedisys has only a 8 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Equity ratings for Amedisys are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of January 2024 and ending today, the 22nd of February 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
17th of August 1994
Category
Healthcare
Classification
Health Care
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana. Amedisys operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. The company has 32.63 M outstanding shares of which 2.96 M shares are presently shorted by private and institutional investors with about 10.95 trading days to cover. More on Amedisys

Amedisys Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Amedisys' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Amedisys or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO PresidentRichard Ashworth
SEC FilingsAmedisys Security & Exchange Commission EDGAR Reports
Old NameAmedeo Resources Plc
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, NASDAQ Composite, SP Midcap 400, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Amedisys report their recommendations after researching Amedisys' financial statements, talking to executives and customers, or listening in on Amedisys' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Amedisys. The Amedisys consensus assessment is calculated by taking the average forecast from all of the analysts covering Amedisys.
Financial Strength
Based on the key indicators related to Amedisys' liquidity, profitability, solvency, and operating efficiency, Amedisys is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March. Financial strength of Amedisys is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Shares Diluted38.9 M37.6 M
Sufficiently Up
Slightly volatile
Weighted Shares38.6 M37.4 M
Sufficiently Up
Slightly volatile
Return on Assets0.06690.069
Sufficiently Down
Slightly volatile
Net Cash Flow from Operations158.8 M153.3 M
Sufficiently Up
Slightly volatile
Current Liabilities376.2 M408.9 M
Significantly Down
Slightly volatile
Total Liabilities806 MB
Significantly Down
Slightly volatile
Gross Margin0.510.5
Fairly Up
Slightly volatile
Total Debt667.5 M618.6 M
Significantly Up
Slightly volatile
Asset Turnover1.241.02
Fairly Up
Slightly volatile
Current Assets393.2 M447.3 M
Fairly Down
Slightly volatile
Total Assets1.8 B2.3 B
Significantly Down
Slightly volatile
Amedisys' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Amedisys' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Amedisys' financial leverage. It provides some insight into what part of Amedisys' total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Amedisys' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Amedisys deploys its capital and how much of that capital is borrowed.
Liquidity
Amedisys cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 537.94 M in liabilities with Debt to Equity (D/E) ratio of 0.53, which is about average as compared to similar companies. Amedisys has a current ratio of 1.04, suggesting that it is in a questionable position to pay out its financial obligations when due. Debt can assist Amedisys until it has trouble settling it off, either with new capital or with free cash flow. So, Amedisys' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amedisys sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amedisys to invest in growth at high rates of return. When we think about Amedisys' use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

158.78 Million
Amedisys (AMED) is traded on NASDAQ Exchange in USA. It is located in 3854 American Way, Baton Rouge, LA, United States, 70816 and employs 18,600 people. Amedisys is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amedisys's market, we take the total number of its shares issued and multiply it by Amedisys's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Amedisys conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 32.63 M outstanding shares of which 2.96 M shares are presently shorted by private and institutional investors with about 10.95 trading days to cover. Amedisys currently holds about 17.96 M in cash with 117.76 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55.
Check Amedisys Probability Of Bankruptcy
Ownership Allocation
Amedisys holds a total of thirty-two million six hundred thirty-three thousand three hundred outstanding shares. The majority of Amedisys outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amedisys to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amedisys. Please pay attention to any change in the institutional holdings of Amedisys as this could imply that something significant has changed or about to change at the company. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Amedisys Ownership Details

Amedisys Stock Price Odds Analysis

What are Amedisys' target price odds to finish over the current price? Based on a normal probability distribution, the odds of Amedisys jumping above the current price in 90 days from now is about 82.67%. The Amedisys probability density function shows the probability of Amedisys stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Amedisys has a beta of 0.2171. This suggests as returns on the market go up, Amedisys average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Amedisys will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Amedisys is significantly underperforming NYSE Composite.
  Odds Below 93.61HorizonTargetOdds Above 93.61
16.45%90 days
 93.61 
82.67%
Based on a normal probability distribution, the odds of Amedisys to move above the current price in 90 days from now is about 82.67 (This Amedisys probability density function shows the probability of Amedisys Stock to fall within a particular range of prices over 90 days) .

Amedisys Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Amedisys that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Amedisys' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amedisys' value.
InstituionRecorded OnShares
Geode Capital Management, Llc2023-09-30
513.7 K
Dimensional Fund Advisors, Inc.2023-12-31
511.6 K
Alliancebernstein L.p.2023-09-30
487.6 K
Hhg Plc2023-09-30
473.5 K
Woodline Partners Lp2023-09-30
462.3 K
Cresset Asset Management, Llc2023-09-30
454.1 K
Van Lanschot Kempen Investment Management Nv2023-09-30
417.2 K
Norges Bank2023-12-31
358 K
Melqart Asset Management (uk) Ltd.2023-09-30
350.3 K
Vanguard Group Inc2023-09-30
3.2 M
Blackrock Inc2023-09-30
M
View Amedisys Diagnostics

Amedisys Historical Income Statement

Amedisys Income Statement is one of the three primary financial statements used for reporting Amedisys's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Amedisys revenue and expense. Amedisys Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Amedisys' Weighted Average Shares is projected to increase significantly based on the last few years of reporting. The current year's Weighted Average Shares Diluted is expected to grow to about 38.9 M, whereas Consolidated Income is forecasted to decline to about 114.2 M. View More Fundamentals

Amedisys Stock Against Markets

Picking the right benchmark for Amedisys stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Amedisys stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Amedisys is critical whether you are bullish or bearish towards Amedisys at a given time. Please also check how Amedisys' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Amedisys without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Latest Portfolios Now

   

Latest Portfolios

Quick portfolio dashboard that showcases your latest portfolios
All  Next Launch Module

Amedisys Corporate Directors

Amedisys corporate directors refer to members of an Amedisys board of directors. The board of directors generally takes responsibility for the Amedisys' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Amedisys' board members must vote for the resolution. The Amedisys board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Jeffrey RideoutDirectorProfile
Nathaniel ZilkhaDirectorProfile
Bruce PerkinsIndependent DirectorProfile
Linda HallIndependent DirectorProfile

How to buy Amedisys Stock?

Before investing in Amedisys, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Amedisys. To buy Amedisys stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Amedisys. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Amedisys stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Amedisys stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Amedisys stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Amedisys, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Amedisys Stock please use our How to Invest in Amedisys guide.

Already Invested in Amedisys?

The danger of trading Amedisys is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Amedisys is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Amedisys. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Amedisys is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Amedisys Stock analysis

When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.001
Earnings Share
0.08
Revenue Per Share
68.4
Quarterly Revenue Growth
(0)
Return On Assets
0.0604
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.